A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic ...

GLP-1 receptor agonists were more cardioprotective in younger people, but reduced HbA1c more with age. The age of type 2 ...

The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...

Moreover, as more companies invest in developing GLP-1 agonists and related therapies ... or shifts in treatment guidelines could significantly impact Novo Nordisk's financial performance and ...

[18] There was no significant difference in weight change between any of the albiglutide dosings, with average weightloss being -1.1 to -1.7 ... fulfill the recent FDA guidelines regarding CV ...

Even under prescription guidelines, drugs like Ozempic come ... in lengthy weight management programmes before a GLP-1 receptor agonist is even considered. Many are discouraged by the high price ...

Researchers had found in a new study that sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 ...

UK: A recent consensus statement from leading UK medical organizations—including the Association of Anaesthetists, the ...